Foreign Product Alert
July 07, 2016
Health Canada is advising Canadians not to use these foreign health products as they may pose a health risk. These products have been found by regulators in other countries to contain undeclared drug ingredients, toxic substances or high levels of heavy metals, which may pose serious health risks. Prescription drugs should only be taken under the supervision of a health care practitioner.
These products are not authorized for sale in Canada and have not been found on the Canadian market, but
Health Product Infowatch
July 04, 2016
The June issue of the Health Product InfoWatch published by Health Canada is now available. This monthly publication provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products. Please consult the index for a complete listing of previous issues.
Health Product Risk Communication
July 13, 2016
BLINCYTO (blinatumomab) and Pancreatitis - Amgen Canada Inc.
There have been reported cases of life-threatening, sometimes fatal pancreatitis associated with the use BLINCYTO (blinatumomab). The Canadian Product Monograph has been updated to reflect this new safety information.
Health Canada Health Product Risk Communication
July 19, 2016
Alere Inc. initiating voluntary withdrawal of Alere INRatio® and INRatio® 2 PT/INR Monitoring System that may pose serious health risks
Alere Inc. is withdrawing the Alere INRatio® and INRatio®2 Prothrombin Time Monitoring Systems (professional and self-test) devices from the Canadian market. These devices measure blood clotting time in patients requiring warfarin and other oral blood-thinning medicines. There is a risk that the Alere devices provide an inaccurate low reading.
Health Canada Advisory